# BIOCON share price, delivery % and history — Biocon Limited

> Delivery percentage for Biocon Limited (BIOCON) against its own history, with 5,578 sessions of split-adjusted NSE data from 2004 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/BIOCON

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 370.3 INR (-1.78% on the day), 2026-09-30
- Delivery: 54.53% of volume taken to demat (20-day average 51.31%)
- Volume: 18.49L shares, turnover ₹68.5Cr
- Relative volume: 0.57× of its own 20-day average

## Technicals

- RSI(14): 33.17
- ATR(14): 9.08
- SMA 50: 408.45, SMA 200: 394.98
- 52-week range: 337.05 – 447.15 (-17.19% from the high)

## Performance

- 1 week -6.25%, 1 month -10.12%, 3 months -11.54%
- 6 months 0.05%, 1 year 3%

## Delivery percentage

- Latest: 54.53% (2026-09-30)
- 20-day average: 51.31%
- 1-year average: 48.27%
- Percentile against its own history: 92th
- Range: 7.77% – 80.06% across 1,728 sessions with a reading

Over the last 20 sessions BIOCON settled 51.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 48.3%, so recent sessions are running 3.0 points higher than usual. The latest session ranks higher than 92% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 60,347.6 crore
- P/E (TTM): 144.93 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 2.56 INR, split-adjusted to match the price series
- Revenue growth: 10% YoY, -4% QoQ
- Profit growth: 53.36% YoY, -31.12% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 8.31% | -54.49% |
| 3y | 11.61% | -12.64% |
| 4y | 19.26% | -15.85% |
| 5y | 19.21% | -11.95% |
| 6y | 17.53% | -10.52% |
| 7y | 16.76% | -12.87% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 3,590.4 | 3,550.5 | 98.4 | 27.1 | -0.13 | 0.75% |
| 2024-12-31 | 3,821.4 | 3,718.4 | 155.9 | 81.1 | 0.21 | 2.12% |
| 2025-03-31 | 4,417 | 3,987.5 | 486.8 | 459.4 | 2.88 | 10.4% |
| 2025-06-30 | 3,941.9 | 3,924.7 | 96.9 | 89.2 | 0.26 | 2.26% |
| 2025-09-30 | 4,295.5 | 4,205.3 | 171.3 | 132.8 | 0.66 | 3.09% |
| 2025-12-31 | 4,173 | 4,064.7 | -67.8 | -51.8 | 1.08 | -1.24% |
| 2026-03-31 | 4,516.6 | 4,241.2 | 247.5 | 198.6 | 0.79 | 4.4% |
| 2026-06-30 | 4,336 | 4,249.4 | 127.6 | 136.8 | 0.87 | 3.15% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 44.68%
- Public: 55.27%
- FII: 8.14%, DII: 23.38%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-05: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_182709_05082026172126_iXBRL_WEB.html
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697926_21072026125942_WEB.xml
- 2026-07-03: dividend
- 2026-07-01: shareholding for 2026-06-29 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1687298_01072026054704_WEB.xml
- 2026-05-08: results for 2026-03-31 consolidated — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_156233_08052026001904_iXBRL_WEB.html
- 2026-05-07: results for 2026-03-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_156226_07052026234928_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1656787_21042026081203_WEB.xml
- 2026-02-12: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142653_12022026195106_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 124 events are indexed for this instrument.

## About the instrument

- Listed: 2004-04-07 — latest session 2026-09-30 (5,578 sessions)
- ISIN: INE376G01013
- Series: EQ
- Liquidity rank: #248 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/BIOCON.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.